MASECO Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77.9K Sell
1,352
-130
-9% -$7.46K ﹤0.01% 148
2026
Q1
$89.8K Hold
1,482
– – ﹤0.01% 123
2025
Q4
$79.9K Buy
+1,482
New +$71.3K ﹤0.01% 137
2025
Q3
– Sell
-5,528
Closed -$256K – 306
2025
Q2
$256K Buy
+5,528
New +$271K 0.01% 95

Other funds holding BMY

MASECO Private Wealth's BMY Position: Q2 2026 in Review

MASECO Private Wealth reduced its Bristol-Myers Squibb (BMY) stake by 8.8% in Q2 2026, selling an estimated $7.46K and leaving 1,352 shares worth $77.9K. The position accounts for ﹤0.01% of the portfolio, ranked #148.

MASECO Private Wealth first reported a position in BMY in Q2 2025 and has held it in 4 quarters since. The position peaked at $256K in Q2 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • MASECO Private Wealth held 1,352 shares of Bristol-Myers Squibb worth $77.9K as of Q2 2026.
  • MASECO Private Wealth sold 130 Bristol-Myers Squibb shares in Q2 2026, an estimated $7.46K.
  • Bristol-Myers Squibb made up ﹤0.01% of MASECO Private Wealth's portfolio in Q2 2026, its #148 holding.
  • MASECO Private Wealth first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 4 quarters since.
  • MASECO Private Wealth's Bristol-Myers Squibb position peaked at $256K in Q2 2025.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on MASECO Private Wealth's 13F filing for Q2 2026, filed 5 Aug 2026.